Series C startup

Who invested in Kalypsys

2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$129Mraised across 2 rounds since 2004, from 2 sources

$29MSeries B$100MSeries C
Latest round
Series C, $100MNov 2006
Step-upi
3.4×
Investors
8
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20052006
$29MSeries B$100MSeries C
First round
Series B, $29M
Aug 2004
Biggest round
$100M
Series C · Nov 2006
Between rounds
2.3 years
from the last two

The rounds

  1. Nov 2006
    Series C$100M4 returning

    From a historical funding record

  2. Aug 2004

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

CMEA VenturesVC firm2rounds
Sprout GroupGrowth equity2rounds
KT Venture GroupGrowth equity2rounds
Tavistock Life SciencesFamily office2rounds
5AM VenturesVC firm1round
Aravis VenturesPrivate equity1round
Novartis Bioventure FundGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Kalypsys

Who invested in Kalypsys?

Kalypsys's investors include CMEA Ventures, Sprout Group, KT Venture Group, Tavistock Life Sciences and 5AM Ventures, and 3 more on record.

How much has Kalypsys raised?

Kalypsys has raised $129M across 2 rounds since 2004.

When did Kalypsys last raise?

Kalypsys's most recent round was a Series C of $100M in Nov 2006.

What was Kalypsys's biggest round?

Its most recent round, $100M in Nov 2006, is also its largest on record.

Who backed Kalypsys first?

Kalypsys's first round on record, in Aug 2004, was backed by 5AM Ventures, CMEA Ventures and Sprout Group and 5 others.

What stage is Kalypsys at?

Kalypsys's latest named round is a Series C, in Nov 2006.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.